Common Contracts

CRINETICS PHARMACEUTICALS, INC. 10,000,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement

Crinetics Pharmaceuticals, Inc. • October 9th, 2024 • Pharmaceutical preparations • New York

• Company
  Crinetics Pharmaceuticals, Inc.
• Filed
  October 9th, 2024
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,000,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to 1,500,000 additional shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”

Upstream Bio, Inc. [•] Shares of Common Stock, par value $0.001 per share Underwriting Agreement

Upstream Bio, Inc. • October 7th, 2024 • Pharmaceutical preparations • New York

• Company
  Upstream Bio, Inc.
• Filed
  October 7th, 2024
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

STANDARDAERO, INC. 60,000,000 Shares of Common Stock Underwriting Agreement

StandardAero, Inc. • September 27th, 2024 • Aircraft engines & engine parts • New York

• Company
  StandardAero, Inc.
• Filed
  September 27th, 2024
• Industry
  Aircraft engines & engine parts
• Jurisdiction
  New York

StandardAero, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 53,250,000 shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”), and certain stockholders of the Company named in Schedule 2 hereto (the “Selling Stockholders”) propose to sell to the several Underwriters an aggregate of 6,750,000 shares of Common Stock of the Company (collectively, the “Underwritten Shares”). In addition, the Selling Stockholders propose to sell, at the option of the Underwriters, up to an additional 9,000,000 shares of Common Stock of the Company (collectively, the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “St